Trial Profile
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 24 Dec 2019
Price :
$35
*
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV infections
- Focus Expanded access; Therapeutic Use
- Sponsors ViiV Healthcare
- 15 Mar 2018 New trial record